key: cord-0884300-5qtwwnw9
authors: Kalantar-Zadeh, Kamyar; Li, Philip Kam-Tao; Tantisattamo, Ekamol; Kumaraswami, Latha; Liakopoulos, Vassilios; Lui, Siu-Fai; Ulasi, Ifeoma; Andreoli, Sharon; Balducci, Alessandro; Dupuis, Sophie; Harris, Tess; Hradsky, Anne; Knight, Richard; Kumar, Sajay; Ng, Maggie; Poidevin, Alice; Saadi, Gamal; Tong, Allison
title: Living Well With Kidney Disease by Patient and Care Partner Empowerment: Kidney Health for Everyone Everywhere
date: 2021-03-05
journal: Kidney Int Rep
DOI: 10.1016/j.ekir.2021.01.008
sha: a9ce7853c0c796a93909b2a0bc96342dc73ba42d
doc_id: 884300
cord_uid: 5qtwwnw9

nan

Patient Priorities for Living Well: a Focus on Life Participation C hronic kidney disease (CKD) and its associated symptoms and treatment can disrupt daily living and impair the quality of life of patients and their family members. Consequently, this impacts treatment satisfaction and clinical outcomes. 1 To advance research, practice, and policy, there is increasing recognition of the need to identify and address patient priorities, values, and goals. 1 Several efforts have addressed these important questions including the Standardised Outcomes in Nephrology initiative, which includes more than 9000 patients, family members, and health professionals from over 70 countries. 2, 3 Children and adults with CKD have consistently given higher priority to symptoms and life impacts, 2,3 whereas health care professionals gave higher priority to mortality and hospitalization. The patient-prioritized outcomes are shown in Figure 1 .

Life participation, defined as the ability to do meaningful activities of life including, but not limited to, work, study, family responsibilities, travel, sport, social, and recreational activities, was established as a critically important outcome across all treatment stages of CKD. 1,2 Patients wanted to be able to live well, maintain their role and social functioning, protect some semblance of normality, have a sense of control over their health and well-being, and be at the center of decision making. The quotations from patients with kidney disease provided in Table 1 demonstrate how life participation reflects the ability to live well with CKD. The World Health Organization specifically defines participation as "involvement in a life situation." The 2021 World Kidney Day (WKD) Steering Committee calls for the inclusion of life participation, a key focus in the care of patients with CKD, to achieve the ultimate goal of living well with kidney disease. This calls for the development and implementation of validated patientreported outcome measures that could be used to assess and address areas of life participation in routine care. Monitoring of life participation could be supported by regulatory agencies as a metric for quality care or to support labeling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients, including life participation.

Patient Empowerment, Partnership, and a Paradigm Shift Toward a Strengths-based Approach to Care Patients with CKD and care partners should be empowered to achieve the health outcomes and life goals. The World Health Organization defines patient empowerment as "a process through which people gain greater control over decisions or actions affecting their health." 4 Understanding the rationale for a lifestyle change, having access to practical assistance, and family support promoted patient empowerment, whereas feeling limited in life participation undermined their sense of empowerment. 5 The 2021 WKD Steering Committee advocates for strengthened partnership with patients in the development, implementation, and evaluation of interventions for practice and policy settings. We urge for greater emphasis on a strengths-based approach as outlined in Table 2 . Different from the medical model, the strengths-based approach acknowledges that each individual has strengths and abilities to overcome the problems and challenges faced and requires collaboration and cultivation of the patient's hopes, aspirations, interests, and values. Structural biases, discrimination, and disparities in the health care system need to be identified.

A care partner is often an informal caregiver who is also a family member of the CKD patient. 6 Care partners may take on a wide range of responsibilities and become more important in CKD care given the heightened complexity in communicative and therapeutic options. They may experience a substantial burden, which may impact family dynamics. Hence, the previously mentioned principles of life participation need to equally apply to care partners involved in CKD care.

In low-and lower-middle-income countries, patient care may often be influenced by internal factors 

The 2021 WKD theme on "Living Well with Kidney Disease" is deliberately chosen to redirect more focus on plans and actions toward achieving patient-centered wellness. "Kidney Health for Everyone, Everywhere" with emphasis on patient-centered wellness should be a policy imperative that can be successfully achieved if policy makers, nephrologists, health care professionals, patients, and care partners place this within the context of comprehensive care. The 2021 WKD Steering Committee would like to promote to the policy makers increasing focus and resources that enable patients to live well with kidney disease. Home dialysis therapies have been consistently found to improve patient quality of life and enhance life participation, and it should be promoted in conjunction with appropriate "assisted dialysis" programs to reduce patient and care partner fatigue and burnout. The principle of equity recognizes that different people with different levels of disadvantage require different approaches and resources to achieve equitable health outcomes. The involvement of primary care physicians, especially in low-and lower-middle-income countries, would be useful in improving the affordability and access to services through the public sector in helping the symptom management of CKD patients and improve their wellness. Primary prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after an effective secondary prevention program, should be promoted. 8 Prevention of CKD progression can be attempted by lifestyle and diet modifications such as a plantdominant low-protein diet and by means of effective pharmacotherapy including the administration of sodium-glucose transport protein 2 inhibitors. 9 The 2021 WKD campaign continues to call for increased awareness of the importance of preventive measures throughout populations, professionals, and policy makers, which is applicable to both developed and developing countries. 8

Effective strategies to empower patients and their care partners strive to pursue the overarching goal of minimizing the burden of CKD-related symptoms in order to enhance patient satisfaction, health-related quality of life, and life participation. To increase education and awareness on the important goal of effective symptom management and patient empowerment, the 2021 WKD Steering Committee has declared 2021 the year of "Living Well with Kidney Disease" despite the coronavirus disease 2019 pandemic that had overshadowed many activities in 2020 and beyond. Although the 2021 WKD campaign continues to emphasize the importance of effective measures to prevent kidney disease and its progression, 8 patients with preexisting kidney disease and their care partners should feel supported to live well through concerted efforts by kidney care communities and other stakeholders throughout the world. 10 Living well with kidney disease is an uncompromisable goal of all kidney foundations, patient groups, and professional societies alike to which the International Society of Nephrology and the International Federation of Kidney Foundation World Kidney Alliance are committed at all times.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

Identifying outcomes important to patients with glomerular disease and their caregivers

Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops

Meaning of empowerment in peritoneal dialysis: focus groups with patients and caregivers

Development of a measure of caregiver burden in paediatric chronic kidney disease: The Paediatric Renal Caregiver Burden Scale

Patients experiences of selfmanagement and strategies for dealing with chronic conditions in rural Malawi

Kidney health for everyone everywhere-from prevention to detection and equitable access to care

Strategies to prevent kidney disease and its progression

Ensuring choice for people with kidney failure -dialysis, supportive care, and hope

UpTo-Date, and ZS-Pharma. PK-TL reports personal fees from Fibrogen and Astra-Zeneca. GS reports personal fees from Multicare, Novartis, Sandoz, and Astra-Zeneca. VL reports nonfinancial support from Genesis Pharma